08 - 09 September 2021 | London, UK

Mark Kiel

Co-Founder, Chief Scientific Officer
Mark Kiel
Dr. Kiel completed his MD/PhD and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he supervises the scientific direction of the Mastermind suite of software tools.


No data was found